乳酸:慢性肾脏病进展中代谢与炎症的缺失环节?
持续增强的肾小管上皮细胞糖酵解与慢性肾脏病进展相关,但机制不明。Wang等在Kidney International报道,糖酵解酶PFKFB3通过乳酸累积增强组蛋白H4赖氨酸12乳酸化,促进NF-κB相关基因转录及炎症和纤维化;抑制PFKFB3可减轻这些效应,提示治疗潜力。
要点
- PFKFB3通过乳酸累积增强H4K12乳酸化促进肾脏纤维化。
- H4K12乳酸化增加NF-κB相关基因转录,促进炎症和纤维化。
- 抑制PFKFB3可减轻上述效应,提示治疗肾脏纤维化潜力。
核心结论
- PFKFB3通过乳酸累积增强H4K12乳酸化,促进NF-κB相关基因转录及炎症和纤维化,抑制PFKFB3可减轻这些效应。
研究设计与样本
- 本文为针对Wang等在Kidney International报道研究的评论文章,未报告原始研究设计与样本量。
主要发现
- 肾小管上皮细胞持续增强的糖酵解与慢性肾脏病进展相关。
- 糖酵解酶PFKFB3通过乳酸累积增强组蛋白H4赖氨酸12乳酸化。
- H4K12乳酸化增加NF-κB相关基因转录,促进炎症和纤维化。
- 抑制PFKFB3可减轻上述效应。
临床怎么用
- 抑制PFKFB3可能为肾脏纤维化提供治疗方向,尚需临床研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Persistent enhancement of glycolysis in kidney tubular epithelial cells has been linked to the progression of chronic kidney disease, although the underlying mechanisms are largely unknown. In this issue of Kidney International, Wang et al. report that the glycolytic enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 plays a crucial role in kidney fibrosis by enhancing histone H4 lysine 12 lactylation through lactate accumulation. This increases the transcription of nuclear factor-κB-related genes and promotes inflammation and fibrosis. Inhibiting 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 reduces these effects, indicating therapeutic potential for kidney fibrosis.
引用
- Nishima N, Tanaka S. Lactate: a missing link between metabolism and inflammation in CKD progression? Kidney Int. 2024. PMID: 39032962. doi:10.1016/j.kint.2024.05.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。